Evaluation of OCT2‐mediated drug–drug interactions between ulotaront and metformin in subjects with schizophrenia

Documenti analoghi

• Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
  di: Ling Shu, et al.
  Pubblicazione: (2024)
• Food–drug interactions risk management: An emergent piece of pharmacovigilance systems
  di: Ana Margarida Advinha, et al.
  Pubblicazione: (2024)
• FDA regulatory considerations for oncology drug development
  di: Hanlim Moon, et al.
  Pubblicazione: (2024)
• Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease
  di: Ashley L. Eadie, et al.
  Pubblicazione: (2024)
• Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
  di: Ana Sofia Martins, et al.
  Pubblicazione: (2024)